The Discovery of RP-2119: A Potent, Selective, and Orally Bioavailable Polθ ATPase Inhibitor
Journal of Medicinal Chemistry · 25.09.2025 · 68 (18) · 19726-19745
DOI: 10.1021/acs.jmedchem.5c02103 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 08.09.2025. Verfasst von Philippe Mochirian und 37 weiteren Autor:innen. Beteiligte Einrichtung: Repare Therapeutics, 7171 Frederick-Banting, Building 2, H4S 1Z9 Montréal, Québec, Canada. Hauptthemen laut MEDLINE: Adenosine Triphosphatases, Antineoplastic Agents, DNA-Directed DNA Polymerase, Drug Discovery. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 40 Literaturangaben.
Abstract (Originalsprache)
DNA polymerase theta (Polθ) plays a critical role in repairing DNA double-strand breaks through microhomology-mediated end joining (MMEJ) and has emerged as a key synthetic lethal drug target in cancers with homologous recombination (HR) deficiencies. Its inhibition has shown a strong potential to synergize with PARP inhibitors, particularly in tumors with deleterious BRCA1 or BRCA2 mutations. Here, we describe the discovery and preclinical development of RP-2119, a selective, potent, and bioavailable Polθ ATPase inhibitor. Starting from a high-throughput ATPase screen combined with literature insights, key vectors for enhancing potency were identified by structural studies using single-particle cryo-electron microscopy (cryo-EM) that revealed the inhibitor binding site. Further optimization of potency and ADME properties led to the identification of RP-2119 with robust in vitro cellular activity in a wide range of HR-deficient cancer cell lines. In HR-deficient cell line- and patient-derived mouse xenografts, RP-2119 demonstrated strong synergy with the PARP inhibitor, olaparib, without exacerbating its hematological toxicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Repare Therapeutics, 7171 Frederick-Banting, Building 2, H4S 1Z9 Montréal, Québec, Canada.
- Paraza Pharma Inc., 2525 Ave. Marie Curie, Montréal, Québec H4S 1Z9, Canada.
- Piramal Pharma Ltd., Village Matoda, Taluka: Sanand, Ahmedabad 382213, Gujarat,India.
- NanoImaging Services, 4940 Carroll Canyon Rd UNIT 115, San Diego, California 92121, United States.
- Molecular Biology Program, Sloan Kettering Institute, MSKCC, 430 E 67th Street, New York, New York 10065, United States.
- Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Ontario M5G 1X5, Canada.
ORCID-Profile: Pavel Mader, Frank Sicheri, W Cameron Black
Zitieren
APA
Mochirian, P., Papp, R., Mathieu, M. C., Ferraro, G. B., Dietrich, E., Liu, B., Bendahan, D., Perryman, A. L., Surprenant, S., Fournier, S., Barzili, B. L., Bonneau-Fortin, A., Yin, S. Y., Leclaire, M. E., Patel, C., Poirier, H., Save, S., Mathieu, Y., Morin, N., …, & Gallant, M. (2025). The Discovery of RP-2119: A Potent, Selective, and Orally Bioavailable Polθ ATPase Inhibitor. Journal of Medicinal Chemistry, 68(18), 19726-19745. https://doi.org/10.1021/acs.jmedchem.5c02103
Vancouver
Mochirian P, Papp R, Mathieu MC, Ferraro GB, Dietrich E, Liu B, et al. The Discovery of RP-2119: A Potent, Selective, and Orally Bioavailable Polθ ATPase Inhibitor. Journal of Medicinal Chemistry. 2025;68(18):19726-19745. doi:10.1021/acs.jmedchem.5c02103
BibTeX
@article{Mochirian2025,
author = {Mochirian, Philippe and Papp, Robert and Mathieu, Marie-Claude and Ferraro, Gino B and Dietrich, Evelyne and Liu, Bingcan and Bendahan, David and Perryman, Alexander L and Surprenant, Simon and Fournier, Sara and Barzili, Bita Lotfollahzadeh and Bonneau-Fortin, Alexanne and Yin, Shou Yun and Leclaire, Marie-Eve and Patel, Charmi and Poirier, Hugo and Save, Sai and Mathieu, Yann and Morin, Nicolas and Godbout, Claude and Burston, Helen E and Zahn, Karl E and Attia, Mohamed A and Pinter, Thomas and Barabé, Francis and Parikh, Paranjay and Jagani, Chandresh and Kang, Gyunghoon and Scapin, Giovanna and Mamane, Yael and Sfeir, Agnel and Mader, Pavel and Sicheri, Frank and Zimmermann, Michal and Roulston, Anne and Morris, Stephen J and Black, W Cameron and Gallant, Michel},
title = {The Discovery of RP-2119: A Potent, Selective, and Orally Bioavailable Polθ ATPase Inhibitor},
journal = {Journal of Medicinal Chemistry},
year = {2025},
volume = {68},
number = {18},
pages = {19726--19745},
doi = {10.1021/acs.jmedchem.5c02103}
}
EUVIMED